1. Cytomegalovirus (CMV) infection in AIDS patients is associated with a CD3 receptor-mediated T cell hyporesponsiveness.
- Author
-
Rowbottom AW, Lepper MW, Sharpstone D, and Gazzard B
- Subjects
- AIDS-Related Opportunistic Infections blood, AIDS-Related Opportunistic Infections virology, Acquired Immunodeficiency Syndrome blood, Acquired Immunodeficiency Syndrome virology, Antibodies, Monoclonal pharmacology, Cytomegalovirus Infections blood, Cytomegalovirus Infections virology, Gene Expression, Humans, Interleukin-2 pharmacology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear immunology, Lymphocyte Activation drug effects, NF-kappa B biosynthesis, T-Lymphocytes drug effects, T-Lymphocytes metabolism, AIDS-Related Opportunistic Infections immunology, Acquired Immunodeficiency Syndrome immunology, CD3 Complex immunology, Cytomegalovirus Infections immunology, Lymphocyte Activation physiology, T-Lymphocytes immunology
- Abstract
HIV+ individuals with human CMV (HCMV) reactivation have a CD3 receptor-mediated T cell hyporesponsiveness when compared with CD4-matched HIV+ and HCMV- control groups. The impairment of proliferation was not reversed by exogenous IL-2. A typical increase in NFkappaB expression was observed following cross-linking of the CD3 receptor, but did not lead to increased CD25 cell surface expression or cell proliferation. The HCMV-induced non-responsiveness was not observed when cells were stimulated with phorbol esters. Lymphocytes cultured with media collected from cell cultures infected with HCMV showed a dose-dependent inhibition in the total T cell population even though cells staining dually for CD8/57 increased in number. The altered growth factor requirements of CD8/57+ cells may therefore account for their presence in AIDS and patients following bone marrow transplantation.
- Published
- 1998
- Full Text
- View/download PDF